9-(hexadecylamino)-3,3-dimethyl-2,4-dihydroacridin-10-ium-1-one
|
|
Descriptors Computed from Structure
Canonical SMILES:
CCCCCCCCCCCCCCCCNC1=C2C(=[NH+]C3=CC=CC=C31)CC(CC2=O)(C)C
Isomeric SMILES
CCCCCCCCCCCCCCCCNC1=C2C(=[NH+]C3=CC=CC=C31)CC(CC2=O)(C)C
InChI
InChI=1S/C31H48N2O/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-19-22-32-30-25-20-17-18-21-26(25)33-27-23-31(2,3)24-28(34)29(27)30/h17-18,20-21H,4-16,19,22-24H2,1-3H3,(H,32,33)/p+1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 2-(4,5-dinitroimidazol-1-yl)-N-(pyridin-3-ylmethyl)ethanamide
- 2-(4,5-dinitroimidazol-1-yl)-N-[3-(4-iodanylphenoxy)-5-nitro-phenyl]ethanamide
- (3R)-N-[[1-(3,4-dimethoxyphenyl)cyclopentyl]methyl]-3-(2-hydroxyphenyl)-N-methyl-3-phenyl-propanamide
- [3-[(5R)-3-(6-bromanyl-2-oxidanylidene-4-phenyl-quinolin-3-ylidene)-5-(4-bromophenyl)pyrazolidin-1-yl]-3-oxidanylidene-propyl]-diethyl-azanium
- 6-bromanyl-3-[(5R)-5-(4-bromophenyl)-1-[3-(diethylamino)propanoyl]pyrazolidin-3-ylidene]-4-phenyl-quinolin-2-one
- N-[4-(6-bromanyl-4-phenyl-quinolin-2-yl)phenyl]-3-morpholin-4-ium-4-yl-propanamide
- N-[4-(6-bromanyl-4-phenyl-quinolin-2-yl)phenyl]-3-morpholin-4-yl-propanamide
- 3-[[2-(3-chloranyl-6-oxidanylidene-5H-benzo[b][1,4]benzodiazepin-11-yl)-2-oxidanylidene-ethyl]-(phenylcarbonyl)amino]propyl-diethyl-azanium
- N-[2-(3-chloranyl-6-oxidanylidene-5H-benzo[b][1,4]benzodiazepin-11-yl)-2-oxidanylidene-ethyl]-N-[3-(diethylamino)propyl]benzamide
- (5Z)-3-ethyl-5-(3-methyl-1,3-benzothiazol-2-ylidene)-2-(3-methyl-4-oxidanylidene-2-sulfanylidene-1,3-thiazolidin-5-ylidene)-1,3-thiazolidin-4-one
